Detalles de la búsqueda
1.
Normalization of impaired glucose tolerance after kidney transplantation is associated with improved beta-cell function.
Am J Physiol Endocrinol Metab;
2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38836778
2.
Shedding light on developmental ERK signaling with genetically encoded biosensors.
Development;
148(18)2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338283
3.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Diabetes Obes Metab;
26(3): 961-970, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073422
4.
Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes.
Endocr J;
71(4): 403-408, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403638
5.
Positive association between proinsulin and fatty liver index in people with type 2 diabetes.
Endocr J;
71(2): 193-197, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123335
6.
Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study).
Endocr J;
2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658349
7.
Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study.
Diabetes Obes Metab;
25(7): 1883-1889, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906821
8.
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Diabetes Obes Metab;
25(6): 1503-1511, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722623
9.
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Pituitary;
26(5): 597-610, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642928
10.
Effects of obesity on CC16 and their potential role in overweight/obese asthma.
Respir Res;
23(1): 174, 2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768822
11.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diabetes Obes Metab;
24(3): 391-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704329
12.
Impact of low-starch high-fiber pasta on postprandial blood glucose.
Nutr Metab Cardiovasc Dis;
32(2): 487-493, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893415
13.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Pituitary;
25(2): 321-327, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088194
14.
Glucokinase as a therapeutic target based on findings from the analysis of mouse models.
Endocr J;
69(5): 479-485, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35418527
15.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Endocr J;
69(5): 495-509, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819409
16.
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic ß-Cell Mass and Function.
Int J Mol Sci;
23(9)2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563495
17.
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Diabetes Obes Metab;
23(10): 2199-2206, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105236
18.
Severe infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report.
BMC Endocr Disord;
21(1): 84, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906651
19.
Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia.
Endocr J;
68(2): 195-200, 2021 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028757
20.
Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
Endocr J;
68(7): 791-805, 2021 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33692246